Clinical Trial: Assessing Prevalence Of Beta Lactamase Production From Clinical Isolates Of Hospitalized Patients And Comparison Of Antibiotic Susceptibility Patterns

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Expert Group On Antibiotic Susceptibility Testing [EGAST] 2008: A Non-Interventional, Multicenter In-Vitro Study To Evaluate The Prevalence Of Beta-Lactamase Producing Str

Brief Summary:

EGAST 2008 is a prospective, non interventional, multicentric study (approximately 2000 isolates from 15- 20 sites).

Objectives:

  • Comparison of antimicrobial susceptibility using disc-diffusion method
  • Assessing prevalence of beta-lactamase producing strains among clinical isolates obtained from hospital in-patients

Detailed Summary: n/a n/a
Sponsor: Pfizer

Current Primary Outcome: Comparison of antimicrobial susceptibility using disc-diffusion method [ Time Frame: duration of trial ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Assessing prevalence of beta-lactamase producing strains among clinical isolates obtained from hospital in-patients [ Time Frame: duration of trial ]

Original Secondary Outcome: Same as current

Information By: Pfizer

Dates:
Date Received: August 4, 2008
Date Started: November 2008
Date Completion:
Last Updated: March 7, 2017
Last Verified: March 2017